Cytokinetics, Incorporated · NASDAQ:CYTK
FMR LLC reported a 9.00% stake in Cytokinetics, Incorporated (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 6, 2026
FMR LLC reported a 9.00% stake in Cytokinetics, Incorporated, 11,135,192 shares, as a passive investor on Mar 31, 2026. Filed May 6, 2026 (Schedule 13G/A).
- Stake
- 9.00%
- Shares
- 11,135,192
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 9.00% | 11,135,192 |
| Abigail P. Johnson | 9.00% | 11,135,192 |
Source
Related
- Cytokinetics, Incorporated
- FMR LLC
- Cytokinetics, Incorporated shareholders
- Schedule 13G/A · FMR LLC · Jul 8, 2026
- Schedule 13G/A · FMR LLC · Aug 7, 2025
- Schedule 13G/A · FMR LLC · Feb 12, 2025
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026